Sign up
Healthed-White-on-Blue

Renal medicine

Article feature image - kidney health outcomes
Dr Chris Bollen
Clinical Articles iconClinical Articles

How better systems can change kidney health outcomes

Practical ways primary care practitioners can help end dialysis by 2050…

Expert/s: Dr Chris Bollen
A,Male,Doctor,Sits,At,A,Desk,In,A,Hospital,
A/Prof Ralph Audehm & Prof Genie Pedagogos
Podcasts iconPodcasts

The Role of SGLT2 Inhibitors in Preventing Dialysis

A/Professor Ralph Audehm and Professor Genie Pedagogos discusses the evidence for using SGLT2 inhibitors in CKD.

Expert/s: A/Prof Ralph Audehm & Prof Genie Pedagogos
Diabetic,Overweight,Man,With,Diabetes,Supplies,And,Devices,On,Table.
Dr Charlotte Hespe & Dr Ramy Bishay
Podcasts iconPodcasts

The role of GLP-1 in the management of CKD in T2D

Dr Charlotte Hespe and Dr Ramy Bishay discuss the latest recommendations for screening and assessing patients for early stage CKD.

Expert/s: Dr Charlotte Hespe & Dr Ramy Bishay
2320123765
Dr Richard Phoon
Clinical Articles iconClinical Articles

Modern CKD management – the game has changed

A new generation of medicines means we can prevent progression to dialysis for many...

Expert/s: Dr Richard Phoon, Kelly Rooke
A,Doctor,Uses,An,Anatomical,Kidney,Model,To,Explain,Renal
Prof Merlin Thomas
Podcasts iconPodcasts

SGLT2s and renal protection

Understand CKD screening priorities, risk mitigation strategies, and the role of SGLT-2 inhibitors in preventing progression and complications.

Expert/s: Prof Merlin Thomas
Kidney,Diseases.,Man,Suffering,From,Pain,With,Inflammation,And,Kidney
Prof Genie Pedagogos, Prof Richard MacIsaac & A/Prof Ralph Audehm
Podcasts iconPodcasts

Panel discussion on GLP1s for chronic kidney disease in type 2 diabetes

Advice and evidence for and role of GLP-1 receptor agonists in the prevention and management of kidney disease in patients with type 2 diabetes will be discussed.

Expert/s: Prof Genie Pedagogos, Prof Richard MacIsaac & A/Prof Ralph Audehm
2477166013
Prof Vlado Perkovic
Podcasts iconPodcasts

Rethinking CKD: From hidden risk to early intervention

Prof Vlado Perkovic outlines how early recognition and evidence-based treatment of CKD can prevent kidney failure and dramatically extend patient lives.

Expert/s: Prof Vlado Perkovic
Composition,Of,Hands,Holding,Kidneys,On,Green,Background,With,Copy
Dr Richard Phoon
Podcasts iconPodcasts

Chronic kidney disease – Delay progression and prevent dialysis

The evidence for the effectiveness of new drug options for chronic disease will be discussed, including when, how and in whom they should be prescribed to.

Expert/s: Dr Richard Phoon
shutterstock_2477166013_Cropped
Dr Bobby Chan
Videos iconVideos

Preventing renal failure in type 2 diabetes – New options

Dr Bobby Chan presents the details of this new treatment for diabetes-related chronic kidney disease including, evidence and effectiveness

Expert/s: Dr Bobby Chan
Artboard 2
Sophia Auld
Clinical Articles iconClinical Articles

Managing CKD with co-existing conditions

Practical tips from the updated Handbook...

Expert/s: Sophia Auld
kidney(2222)
Sophia Auld
Clinical Articles iconClinical Articles

CKD medical management – key updates

PBS-listed drugs for CKD can slow deterioration by years, but early diagnosis is paramount...

Expert/s: Sophia Auld
Illustration,Of,Liver,On,Woman's,Body,Against,Gray,Background,,Hepatitis,
Dr Ronald Castelino
Podcasts iconPodcasts

DOAC dosing in special situations – Renal impairment, liver disease and obesity

Inappropriate DOAC dosing is a common problem- recognise which patients require reduced dosage, what GPs can do to optimise the dosage in view of the specific clinical characteristics of each patient.

Expert/s: Dr Ronald Castelino

Discover

Healthed

CPD platform

Upcoming Healthed Webcast

Practical Strategies for Behaviour Management in Dementia

Tuesday 7th July, 7pm - 9pm AEST

Speaker

Dr Chrys Pulle

Geriatrician; Principal Investigator, Internal Medicine and Dementia Research Unit, The Prince Charles Hospital

Dr Chrys Pulle provides practical and evidence-based recommendations on how best these behavioural and psychological symptoms can be assessed and managed.

Register for webcast